VR22 Antibody Blocking peptide
VR22 Antibody Blocking peptide
Product Specifications
Product Name Alternative
Catenin alpha-3, Alpha T-catenin, Cadherin-associated protein, CTNNA3 {ECO:0000312, EMBL:AAF218011, ECO:0000312, HGNC:HGNC:2511}
UniProt
Q9UI47
Field of Research
Cardiovascular Disease, Epigenetics
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the Center region of human VR22. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
